Obesity 31 , 21712177 (2023)
J Occup Med
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Vitamin C, dosed at 100% of the reference nutritional values, supports normal collagen formation, essential for dermal structure, while protecting cells against oxidative stress
USA103, 1809518100 (2006)
Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists
